Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
MEI, after failed Infinity merger last year, faces its end
A doomed merger sent Infinity pharma filing for bankruptcy last year. Now, the other half of that ill-fated deal is facing its end as well.
Annalee Armstrong
Jul 22, 2024 10:00am
Ikena cuts Hippo med, half of staff in latest reprioritization
May 29, 2024 9:15am
LianBio lays off half of workforce as biotech winds down
Feb 13, 2024 9:10am
Windtree's search for help shifts to full company sale
Jan 31, 2024 10:35am
2seventy splits again, sending cell therapy R&D to Regeneron
Jan 30, 2024 1:30pm
Gene editing biotech Graphite merges into vision loss biotech
Nov 15, 2023 9:57am